European Union regulators have asked companies seeking to complete their desired mergers to delay submitting antitrust filings due to the coronavirus outbreak.
That could affect the timelines of agreed deals. Among the biggest is the London Stock Exchange’s (LSE) proposed acquisition of Refinitiv.
LSE agreed last year to buy the data and analytics firm in a US$27 billion deal aimed at offering trading across regions and currencies.
European competition authorities were expected to rule on the deal “around the summer,” an LSE board member said in January.
But on Monday, March 16, a spokesperson for the European Commission said companies had been encouraged to delay merger notifications until further notice, pointing to “the complexities and disruptions caused by the coronavirus.”
The Commission had adopted “measures to respect the experts’ advice on social distancing,” he said. “This will affect to some extent our current working habits, but the Directorate-General for Competition is prioritizing actions to fulfill its mission and meet legal deadlines.”
LSE stated it remained committed to closing the transaction during the second half of 2020, adding that it continued to “engage constructively with the European Commission and other relevant regulators and stakeholders.
Full Content: Insurance Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
